Adverum Biotechnologies has announced the initiation of the ARTEMIS phase 3 study, designed to evalu...

Nicox, a global ophthalmology company, presented new data on its intraocular pressure (IOP)-lowering...

Opthea has announced new findings from its phase 2b clinical trial evaluating sozinibercept for trea...

Altris AI has introduced its Advanced Optic Disc (OD) Analysis module to enhance glaucoma detection ...

Outlook Therapeutics has resubmitted its Biologics License Application (BLA) to the U.S. Food and Dr...

Professor Michael Belkin, Head of NurExone Biologic’s Ophthalmology Project, will receive the Lifeti...

RetinalGenix Technologies Inc. has successfully begun patient imaging using the first prototype of i...

Perceive Pharma has announced the closing of a $15 million Series A funding round, supported by lead...

Opus Genetics has completed enrollment in the VEGA-3 Phase 3 clinical trial evaluating phentolamine ...

Luxa Biotechnology LLC has announced that the U.S. Food and Drug Administration (FDA) has granted Re...